People regulating themselves to achieve weight loss (Prevail Trial)

ISRCTN ISRCTN14148239
DOI https://doi.org/10.1186/ISRCTN14148239
Secondary identifying numbers 11/2018
Submission date
29/11/2018
Registration date
13/12/2018
Last edited
03/11/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
This study tests a newly developed weight loss intervention that aims to make daily self-weighing a more effective tool for weight loss. The intervention guides participants through a self-regulation process after self-weighing: participants will be asked to track their weight measurements using a weight loss tracker. They will receive daily questionnaires asking them to plan a weight loss action for each day. On a weekly basis they will be asked to reflect on how their behaviours might explain their weight change and to evaluate the weight loss actions they used throughout the week.

Who can participate?
People aged 18 or over with a Body Mass Index (BMI) of 30 kg/m2 or over

What does the study involve?
Participants are randomly allocated to the treatment group or the control group. In the treatment group participants receive the new intervention, in the control group they are asked to simply weigh themselves daily. Participants attend two meetings with the research team, one at the start of the study and one at follow-up. At the first meeting participants, weight, height and body composition are measured. They also complete a questionnaire asking for their demographic background and previous experiences of weighing themselves. They then follow the assigned intervention for 8 weeks. After completing the intervention, participants in the treatment group receive a questionnaire by email asking about their opinions on the intervention components. At the follow-up meeting participants' weight and body composition are measured again. The changes in weight and body composition are compared across the control and treatment groups to see whether the treatment group lost more weight. Some participants in the intervention group are interviewed about their experiences in the study.

What are the possible benefits and risks of participating?
Everyone taking part in the study will receive an intervention that has the potential to help with losing weight. Everybody will also receive information about how to weigh oneself in the best way to achieve reliable results. Participants will be sent a lay summary of the results after analysis is completed. Daily weighing carries no specific health risks. Recent studies have shown that self-weighing leads to higher body satisfaction as well as decreases in depression levels. The researchers are therefore confident that self-weighing does not pose a risk for our participants. However, they realise that there is a theoretical risk that people with eating disorders might be adversely affected by daily weight measurements. They therefore decided to exclude this population group from the study.

Where is the study run from?
Nuffield Department of Primary Care Health Sciences (UK)

When is the study starting and how long is it expected to run for?
March 2018 to June 2019

Who is funding the study?
NIHR CLAHRC Oxford (UK)

Who is the main contact?
Kerstin Frie
kerstin.frie@phc.ox.ac.uk

Contact information

Ms Kerstin Frie
Scientific

Nuffield Department of Primary Care Health Sciences
University of Oxford
Gibson Building
Radcliffe Observatory Quarter
Woodstock Road
Oxford
OX2 6GG
United Kingdom

ORCiD logoORCID ID 0000-0002-4717-5874
Phone +44 (0)1865289317
Email kerstin.frie@phc.ox.ac.uk

Study information

Study designSingle-centre individually randomised open two-arm parallel-group design
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Home
Study typeTreatment
Participant information sheet Please contact us via email to request a participant information sheet
Scientific titleA proof of concept trial of a self-regulation intervention for weight loss
Study acronymPREVAIL
Study hypothesisA behavioural intervention that guides users through a self-regulation process following self-weighing is more effective for weight loss than simple daily weighing.
Ethics approval(s)NHS Health Research Authority, 20/11/2018, REC ref: 18/SC/0482
ConditionObesity
InterventionAll eligible participants will be randomised with an allocation ratio of 1:1 to the self-regulation intervention or control group after consent has been taken. A randomisation sequence, stratified by GP and using stratified block randomisation with randomly varying block sizes of 2 and 4 will be generated using a computer algorithm at http://www.randomization.com. Allocations will be concealed in numbered, sealed envelopes by an independent researcher in the department and handed to the researcher who will conduct the baseline visit with the participants.

Participants in the treatment group will be guided through a self-regulation process following self-weighing for eight weeks. Participants will be asked to weigh themselves every day using provided standard body scales and keep track of their weight loss progress using a freely available weight-tracking app. They will be sent automated daily self-regulation prompts via email using the online software Qualtrics. The prompt will ask participants to plan a specific weight loss action for the day (e.g. do not eat between meals). They will be asked to specify how they are going to perform the action and think about any cues they might use to remind themselves of the task. They will then be prompted to construct if-then plans to account for potential barriers. Participants will be asked to choose a category of actions (e.g. actions surrounding physical activity) at the beginning of the week and will be offered action plans within this category for the whole week. By the end of the week, they will thus be able to make conclusions about the effectiveness of this category of actions. On a weekly basis, participants will receive an email with feedback on the weeks progress. The email will also include a link to another self-regulation prompt using the online software Qualtrics, in which participants will be asked to reflect on their behaviour throughout the week and try to explain observed weight changes. The questionnaire will also ask participants to reflect on the effectiveness of the week’s strategy (i.e., category of actions), and whether they would like to continue using this category of actions in the future. At the start of the next week, participants will be encouraged to keep performing effective weight loss actions while trying out a new set of actions. After the eight weeks of the intervention are finished, participants will be sent a final online questionnaire via email (Qualtrics), which asks them about their opinion regarding the usefulness of the intervention components.

Participants in the control group will be asked to weigh themselves daily for eight weeks. Participants will receive special body scales, which are equipped with a SIM card and automatically transfer their weight measurements to a secure research server via the 3G/4G network. This data is used to assess adherence to daily weighing in the control group.
Intervention typeBehavioural
Primary outcome measureThe early effectiveness of a self-regulation intervention compared to unsupported daily weighing for weight loss, measured through change in body weight between baseline and 2 months follow-up by condition
Secondary outcome measures1. The usage and effectiveness of the self-regulation intervention components, measured across the two months of the study through:
1.1. Adherence to intervention components, assessed through weight records and daily action-planning/weekly evaluation questionnaires
1.2. Action plan use and evaluation, based on information from daily and weekly questionnaires, and 2 months follow-up interviews
2. Participant experiences of the self-regulation intervention for weight loss, measured at 2 months follow-up through:
2.1. Liking and perceived effectiveness of intervention features based on 2 months follow-up interviews
2.2. Barriers and unmet needs for successful weight loss, assessed in 2 months follow-up interviews
Overall study start date15/03/2018
Overall study end date31/10/2019

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants100
Total final enrolment100
Participant inclusion criteria1. Participant is willing and able to give informed consent for participation in the study
2. Aged 18 years or above
3. Body Mass Index ≥30 kg/m2
4. Ownership of an Apple or Android smartphone
Participant exclusion criteria1. Unable to understand English
2. Measures body weight more than once a week
3. Currently or recently (within 3 months of study entry) attended a weight management programme or currently participating in another weight loss study
4. Lost more than 5% of current body weight in the last six months
5. Had bariatric surgery, or scheduled for bariatric surgery
6. Pregnant, or planning to become pregnant during the course of the study
7. Have an electronic medical implant, such as a pacemaker
8. Have ever had or been diagnosed with an eating disorder
9. Patients that the GP judges not able to meet the demands of either treatment programme or measurement schedule. This may include severe medical problems not listed above or severe psychiatric problems including substance misuse that make following the treatment programme or adhering to the protocol unlikely
Recruitment start date14/01/2019
Recruitment end date22/08/2019

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Nuffield Department of Primary Care Health Sciences
Radcliffe Primary Care Building
Radcliffe Observatory Quarter
Woodstock Road
Oxford
OX2 6GG
United Kingdom

Sponsor information

University of Oxford / Clinical Trials and Research Governance (CTRG)
University/education

Joint Research Office
1st Floor, Boundary Brook House
Churchill Drive
Headington
Oxford
OX3 7LQ
England
United Kingdom

Website https://researchsupport.admin.ox.ac.uk/ctrg
ROR logo "ROR" https://ror.org/052gg0110

Funders

Funder type

Government

NIHR CLAHRC Oxford

No information available

Results and Publications

Intention to publish date31/10/2020
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planThe trial results will be published and all who meet the criteria for authorship will be listed as authors. Results will also be presented at lay and scientific forums. There are no plans to publish any other materials from the study.
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available as they may contain information that could compromise research participant privacy. Quantified data from the trial, such as weight measurements, may be published as supplemental material to the main outcome paper. All data will be held securely on a departmental drive and will only be accessible by members of the trial management group.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Statistical Analysis Plan version V1.0 21/10/2019 28/10/2019 No No
Protocol article protocol 08/12/2019 22/10/2020 Yes No
Results article results 01/09/2020 03/11/2020 Yes No
HRA research summary 28/06/2023 No No

Additional files

ISRCTN14148239_V1.0_21Oct19.pdf
Uploaded 28/10/2019

Editorial Notes

03/11/2020: Publication reference added.
22/10/2020: Publication reference added.
28/10/2019: Uploaded statistical analysis plan.
09/09/2019: Total final enrolment number added.
08/08/2019: The recruitment end date was changed from 31/07/2019 to 22/08/2019.
08/05/2019: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/04/2019 to 31/07/2019.
2. The overall end date was changed from 30/06/2019 to 31/10/2019.
3. The intention to publish date was changed from 30/06/2020 to 31/10/2020.